HCM (Hutchison MediPharma) Korxona qiymati/daromad multiplikatori

Ommaviy kompaniya hutch-med.com (HCM) logotipi

HUTCHMED (HCM) kompaniyasining shaxsiy zavodlari va R&D markazlari global eksport uchun GMP standartlarini joriy etgan holda maksimal samaradorlikda ishlamoqda. Kompaniyaning EV/Revenue koeffitsiyenti ushbu tendentsiyani kuzatishga yordam beradi, 1962.76 ko'rsatkichi esa joriy baholash holatini aks ettiradi. Holding moliyaviy barqarorlikni ta'minlash uchun onkologik dori vositalarini ishlab chiqishni Xitoydagi distribyutsiya bilan birlashtirib, klinik sinovlar va marketingni tashqi pudratchilarga topshiradi.

Hutchison MediPharma - HCM Kompaniya qiymatining daromadga nisbati (davr: 23.11.2025 - 20.11.2026)

hutch-med.com - tahliliy kesimlar va asosiy koʻrsatkichlar (HCM)

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Kompaniyaning dastlabki tahlili:HUTCHMED (China) Limited HCM
HUTCHMED (China) Limited tovar namunasi

HUTCHMED (HCM) tomonidan innovatsion dori vositalarining global tijoratlashtirilishi strategik sherikliklarga tayanadi, bu esa daromadlar o'sish sur'atlariga bevosita ta'sir ko'rsatadi. GURU.Markets platformasida EV/Revenue ko'rsatkichi tahlil qilish orqali investor biznes qiymatini sof qarzni hisobga olgan holda baholaydi va past baholash fundamental to'xtash natijasi ekanligini yoki past baholangan aktivga kirish nuqtasini anglatishini aniqlaydi.

HUTCHMED (China) Limited raqobatchilari tahlili

Korxona qiymati/daromad multiplikatori Incyte Corporation|NUVB: EV/Sales multiplikatori|Korxona qiymatining sotuvga nisbati Day One Bio DAWN|Kompaniya qiymatining daromadga nisbati MNPR|Korxona qiymati/daromad multiplikatori Inhibrx Biosciences INBX|Kompaniya qiymatining daromadga nisbati IMAB (I-Mab Biopharma Co., Ltd.)|FENC (Fennec Pharmaceuticals Inc.) - Biznes qiymatining daromadga nisbati|Heron Therapeutics, Inc. - Kompaniya qiymatining daromadga nisbati|Korxona qiymati/daromad koeffitsiyenti NVCT (Nuvectis Pharma)|Coherus BioSciences, Inc. - EV/Sales multiplikatori|Biznes qiymatining daromadga nisbati CRBP (Corbus Pharma)|CRDF: EV/Sales multiplikatori|Korxona qiymati/daromad multiplikatori beyondspringpharma.com (BYSI)|Korxona qiymatining daromadga nisbati bioatla.com|LIXT: Biznes qiymatining daromadga nisbati|EV/Sales multiplikatori CTXR|EV/Sales multiplikatori Cellectar Corp (CLRB)|Korxona qiymatining daromadga nisbati BioLineRx Corp BLRX|CANF (Can-Fite BioPharma Ltd.) - Korxona qiymatining sotish hajmiga nisbati|APRE: Kompaniya qiymatining daromadga nisbati|Korxona qiymati/daromad multiplikatori Kazia Therapeutics Limited|Silexion Therapeutics Corp (SLXN) - Korxona qiymatining daromadga nisbati|Kompaniya qiymati va daromad nisbati NCNA|CMRX (Chimerix, Inc.) - EV/Sales multiplikatori|Korxona qiymati/daromad multiplikatori Cyclacel Pharmaceuticals CYCC|G1 Therapeutics Inc. (GTHX) - Biznes qiymatining daromadga nisbati|KRON - Korxona qiymati/daromad multiplikatori|Kintara Therapeutics, Inc. - Kompaniya qiymatining daromadga nisbati|Korxona qiymati/daromad koeffitsiyenti ONCT (Oncternal)|Portage Biotech Corp - EV/Sales multiplikatori